Zerbaxa 1 g per 10 mL / 0.5 g per 10 mL injection, powder, lyophilized, for solution

Where it's made

This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Merck Sharp & Dohme LLC names for other drugs.

Recalls

• Dec 21, 2020 · Class II · Merck Sharp & Dohme
  Lack of assurance of sterility: The results of sterility tests of seven batches of product were out of specification. Five of these batches tested positive for Ralstonia pickettii and two batches produced turbid results that could not be further identified. While all product distributed to the market has met the registered specifications for release, including for sterility, it was manufactured on the same equipment as the affected batches.
  Lots: All lots within expiry: SP1488 08-Jun-21; SP1490 11-Jun-21; SP1492 13-Jun-21; SP1493 15-Jun-21; SP1494 21-Jun-21; SP1495 23-Jun-21; SP1496 25-Jun-21; SP1497 27-Jun-21; SP1498 29-Jun-21; SP1509 20-Sep-21; SP1510 26-Sep-21; SP1515 16-Oct-21; SP1517 23-Oct-21; SP1518 25-Oct-21; SP1519 30-Oct-21; SP15…

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Ceftolozane and Tazobactam: every company that makes it

Form

injection, powder, lyophilized, for solution, intravenous

Strength

1 g per 10 mL / 0.5 g per 10 mL

Approval

NDA NDA206829

On the market since

Dec 19, 2014

Package NDCs

67919-030-01

Official label

DailyMed (National Library of Medicine), updated May 12, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?